liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Risk assessment models and survival in pulmonary arterial hypertension: a SPAHR analysis
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.ORCID iD: 0000-0002-2395-8989
Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, USA.
Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, USA.ORCID iD: 0000-0001-6524-2412
Department of Cardiology, University Hospital Uppsala, Uppsala, Sweden.
Show others and affiliations
2024 (English)In: The Journal of Heart and Lung Transplantation, ISSN 1053-2498, E-ISSN 1557-3117, Vol. 44, no 11, p. 1787-1797Article in journal (Refereed) Published
Abstract [en]

 Background:  Multicomponent improvement (MCI) is a novel endpoint for predicting survival in patients with pulmonary arterial hypertension (PAH), included in the sotatercept clinical program. For the first time, we investigated the prognostic value of MCI, ESC/ERS 4-strata risk (4SR) assessment, and the non-invasive French risk stratification score (FRS), for predicting survival in PAH patients in Sweden. All risk prediction models are based on three parameters: WHO-FC (World Health Organization Functional Class), NT-proBNP, and 6MWD (6-minute walk distance).

 Methods:  Data from the Swedish PAH & CTEPH Registry (SPAHR) collected 2008-2021 were used for the analyses. The association of MCI achievement, 4SR, and FRS calculated at 6 months (6M), with transplant-free (TF) survival was investigated in the whole cohort, as well as categorized by age (<65 and ≥65 years). All risk prediction models are based on three parameters: WHO-FC (World Health Organization Function Class), NT-proBNP, and 6MWD (6-minute walk distance). Kaplan-Meier estimate/Log-Rank test and Cox proportional model were used for survival analyses.

 Results:  The study included 411 patients (70% women) with a median [IQR] age of 66y.21 At 6M, the mean (SD) NT-proBNP decrease was 808 (603) and the mean 6MWD increase was 44 (11) meters. Median survival/follow-up time was 3.5y [1.7, 5.4]. After adjustment for sex and comorbidities, achievement of MCI independently predicted TF-survival; one MCI-criterion met (HR 0.65; CI 0.46-0.92, p=0.015); two MCI-criteria met (HR 0.45; CI 0.31-0.66, p<0.001); all three MCI-criteria met (HR 0.32; CI 0.21-0.52, p<0.001). Likewise, 4SR and FRS demonstrated a strong association with TF-survival with patients achieving lower risk scores exhibiting longer survival compared to those with higher risk scores. Patients ≥65Y more often had connective tissue disease-associated PAH, lower DLCO, more pronounced comorbidity burden, higher risk at baseline, less improvement during follow-up, and worse TF-survival then patients <65Y.

 Conclusion:  All models were found to have prognostic relevance for TF-survival. Risk prediction was incremental with the number of low-risk criteria met, while improvements in only one of 6MWD, NT-proBNP, or FC showed a modest association with survival. The risk assessment tools predicted outcome in patients across both age categories.

Place, publisher, year, edition, pages
Elsevier BV , 2024. Vol. 44, no 11, p. 1787-1797
Keywords [en]
multicomponent improvement; pulmonary arterial hypertension; risk assessment; survival
National Category
Geriatrics
Identifiers
URN: urn:nbn:se:liu:diva-215660DOI: 10.1016/j.healun.2024.10.029ISI: 001609248000020PubMedID: 39536922Scopus ID: 2-s2.0-105020034297OAI: oai:DiVA.org:liu-215660DiVA, id: diva2:1977477
Note

Funding Agencies|Karolinska Institutet; MSD

Available from: 2025-06-26 Created: 2025-06-26 Last updated: 2025-11-28

Open Access in DiVA

fulltext(2079 kB)217 downloads
File information
File name FULLTEXT01.pdfFile size 2079 kBChecksum SHA-512
09af6a65c35b05bb6a2b6779e40ab82380bba6a4ddfbfb01566713f2bed7e1a14929ffac8f76a3ad4a19dd2b77c9336d0acc69a2306180f187a3acd87b8b72bf
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Papageorgiou, Joanna-Maria

Search in DiVA

By author/editor
Hjalmarsson, ClaraWeiss, TraceyPapageorgiou, Joanna-MariaRådegran, GöranWåhlander, HåkanKjellström, Barbro
By organisation
Division of Nursing Sciences and Reproductive HealthFaculty of Medicine and Health SciencesDepartment of Cardiology in Linköping
In the same journal
The Journal of Heart and Lung Transplantation
Geriatrics

Search outside of DiVA

GoogleGoogle Scholar
Total: 224 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 120 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf